Thromb Haemost 1992; 68(02): 185-188
DOI: 10.1055/s-0038-1656346
Original Article
Schattauer GmbH Stuttgart

Lysine-Binding Heterogeneity of Lp(a): Consequences for Fibrin Binding and Inhibition of Plasminogen Activation

C Bas Leerink
The Department of Clinical Chemistry, University Hospital Utrecht, Utrecht, The Netherlands
,
Pieter F C C M Duif
The Department of Clinical Chemistry, University Hospital Utrecht, Utrecht, The Netherlands
,
Joke A Gimpel
The Department of Clinical Chemistry, University Hospital Utrecht, Utrecht, The Netherlands
,
Wouter Kortlandt
The Department of Clinical Chemistry, University Hospital Utrecht, Utrecht, The Netherlands
,
Bonno N Bouma
1   The Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands
,
Herman J M van Rijn
The Department of Clinical Chemistry, University Hospital Utrecht, Utrecht, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 08. November 1991

Accepted after revision 13. März 1992

Publikationsdatum:
03. Juli 2018 (online)

Preview

Summary

Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for atherosclerosis. Lp(a) consists of a LDL-like moiety with an additional glycoprotein, apo(a), linked to apolipoprotein B-100. Apo(a) has a high homology with plasminogen (Pg). In vivo, Pg is activated on a fibrin surface by tissue Pg activator (tPA). We prepared Lp(a) from plasma by sequential ultracentrifugation followed by lysine-sepharose affinity chromatography. We found that a changing (donor dependent) fraction of the Lp(a) did not bind to lysine-sepharose. This fraction, designated Lp(a)lys–, was further purified using gel filtration. Bound Lp(a) [Lp(a)lys+] was eluted with 0.2 M EACA. Apo(a) isoforms in both fractions were identical. In contrast Lp(a)lys+ inhibited Pg activation by tPA in vitro (IC50% 20 mg/1), whereas Lp(a)lys– did not. In addition Lp(a)lys– did not bind to CNBr-digested fibrinogen whereas Lp(a)lys+ did (K d, app = 0.2 nM). Therefore we conclude that a changing donor dependent fraction of human plasma Lp(a) does not inhibit Pg activation in vitro and does not bind to CNBr-digested fibrinogen.